by Camilla S. Graham, Susanna Naggie, David P. Holland et al.
Clin Infect Dis. (2017) 64 (1): 92-99
Hepatitis C virus (HCV) direct-acting antivirals has renewed discussions as to whether these therapies could be used to prevent infection. The authors review transmission of HCV in the healthcare setting and provide an argument against post-exposure prophylaxis based on a simple cost analysis.